LobbyingInternational Myeloma Foundation lobbying by quarter
International Myeloma Foundation's latest lobbying report covers Q2 2026, at $23K. The four quarters Q4 2025–Q3 2026 total $69K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
International Myeloma Foundation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $69K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $83.9K | 2 |
| Q1 2023 | $94.7K | 2 |
| Q2 2023 | $96.4K | 2 |
| Q3 2023 | $81.8K | 2 |
| Q4 2023 | $97.8K | 2 |
| Q1 2024 | $69.6K | 2 |
| Q2 2024 | $56.1K | 2 |
| Q3 2024 | $31.7K | 1 |
| Q4 2024 | $38.5K | 1 |
| Q1 2025 | $38.5K | 1 |
| Q2 2025 | $25.1K | 1 |
| Q3 2025 | $81.4K | 1 |
| Q4 2025 | $23K | 1 |
| Q1 2026 | $23K | 1 |
| Q2 2026 | $23K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$328.1K · 22 reports
- Health issues$328.1K · 22 reports
- Defense$208.1K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES22 reports
- SENATE22 reports
- Centers For Disease Control & Prevention (CDC)7 reports
- White House Office7 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseInternational Myeloma Foundation | $624.4K | 15 quarters |
| Cavarocchi Ruscio Dennis Associates | $240K | 7 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/03for Q2 | In-house | $23K |
| 05/02for Q1 | In-house | $23K |
| 04/23for Q1 | In-house | $23K |
| 04/23for Q4 2025 | In-house | $23K |
| 01/23for Q4 2025 | In-house | $81.4K |
| 25/11/06for Q3 2025 | In-house | $81.4K |
| 25/08/22for Q2 2025 | In-house | $25.1K |
| 25/08/06for Q2 2025 | In-house | $38.5K |
| 25/04/22for Q1 2025 | In-house | $38.5K |
| 25/01/27for Q4 2024 | In-house | $38.5K |
| 24/12/02for Q3 2024 | In-house | $31.7K |
| 24/11/07for Q3 2024 | In-house | $46.1K |
| 24/08/22for Q2 2024 | In-house | $46.1K |
| 24/08/02for Q2 2024 | In-house | $39.6K |
| 24/07/22for Q2 2024 | Cavarocchi Ruscio Dennis Associates | $10K |
| 24/05/29for Q1 2024 | In-house | $39.6K |
| 24/05/07for Q1 2024 | In-house | $57.8K |
| 24/04/22for Q1 2024 | Cavarocchi Ruscio Dennis Associates | $30K |
| 24/02/09for Q4 2023 | In-house | $57.8K |
| 24/02/07for Q4 2023 | In-house | $41.8K |